BMY logo

Bristol-Myers Squibb (BMY) Revenue

Annual revenue:

$48.30B+$3.29B(+7.32%)
December 1, 2024

Summary

  • As of today (April 14, 2025), BMY annual revenue is $48.30 billion, with the most recent change of +$3.29 billion (+7.32%) on December 1, 2024.
  • During the last 3 years, BMY annual revenue has risen by +$1.92 billion (+4.13%).
  • BMY annual revenue is now at all-time high.

Performance

BMY Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

Quarterly revenue:

$12.34B+$450.00M(+3.78%)
December 1, 2024

Summary

  • As of today (April 14, 2025), BMY quarterly revenue is $12.34 billion, with the most recent change of +$450.00 million (+3.78%) on December 1, 2024.
  • Over the past year, BMY quarterly revenue has increased by +$865.00 million (+7.54%).
  • BMY quarterly revenue is now at all-time high.

Performance

BMY Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

TTM revenue:

$48.30B+$865.00M(+1.82%)
December 1, 2024

Summary

  • As of today (April 14, 2025), BMY TTM revenue is $48.30 billion, with the most recent change of +$865.00 million (+1.82%) on December 1, 2024.
  • Over the past year, BMY TTM revenue has increased by +$3.29 billion (+7.32%).
  • BMY TTM revenue is now at all-time high.

Performance

BMY TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

BMY Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.3%+7.5%+7.3%
3 y3 years+4.1%+7.5%+7.3%
5 y5 years+84.7%+7.5%+7.3%

BMY Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7.3%at high+12.6%at high+7.5%
5 y5-yearat high+84.7%at high+21.9%at high+55.8%
alltimeall timeat high+539.1%at high+642.6%at high+2456.2%

Bristol-Myers Squibb Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$48.30B(+7.3%)
$12.34B(+3.8%)
$48.30B(+1.8%)
Sep 2024
-
$11.89B(-2.5%)
$47.44B(+2.0%)
Jun 2024
-
$12.20B(+2.8%)
$46.51B(+2.1%)
Mar 2024
-
$11.87B(+3.4%)
$45.53B(+1.2%)
Dec 2023
$45.01B(-2.5%)
$11.48B(+4.7%)
$45.01B(+0.2%)
Sep 2023
-
$10.97B(-2.3%)
$44.94B(-0.6%)
Jun 2023
-
$11.23B(-1.0%)
$45.19B(-1.4%)
Mar 2023
-
$11.34B(-0.6%)
$45.85B(-0.7%)
Dec 2022
$46.16B(-0.5%)
$11.41B(+1.7%)
$46.16B(-1.2%)
Sep 2022
-
$11.22B(-5.6%)
$46.74B(-0.9%)
Jun 2022
-
$11.89B(+2.1%)
$47.14B(+0.4%)
Mar 2022
-
$11.65B(-2.8%)
$46.96B(+1.2%)
Dec 2021
$46.38B(+9.1%)
$11.98B(+3.1%)
$46.38B(+2.0%)
Sep 2021
-
$11.62B(-0.7%)
$45.47B(+2.4%)
Jun 2021
-
$11.70B(+5.7%)
$44.38B(+3.7%)
Mar 2021
-
$11.07B(+0.0%)
$42.81B(+0.7%)
Dec 2020
$42.52B(+62.6%)
$11.07B(+5.0%)
$42.52B(+7.9%)
Sep 2020
-
$10.54B(+4.1%)
$39.40B(+13.0%)
Jun 2020
-
$10.13B(-6.0%)
$34.86B(+12.4%)
Mar 2020
-
$10.78B(+35.7%)
$31.01B(+18.6%)
Dec 2019
$26.14B(+15.9%)
$7.95B(+32.3%)
$26.14B(+8.2%)
Sep 2019
-
$6.01B(-4.2%)
$24.17B(+1.3%)
Jun 2019
-
$6.27B(+6.0%)
$23.86B(+2.4%)
Mar 2019
-
$5.92B(-0.9%)
$23.29B(+3.2%)
Dec 2018
$22.56B(+8.6%)
$5.97B(+5.0%)
$22.56B(+2.4%)
Sep 2018
-
$5.69B(-0.2%)
$22.04B(+2.0%)
Jun 2018
-
$5.70B(+9.8%)
$21.60B(+2.7%)
Mar 2018
-
$5.19B(-4.7%)
$21.04B(+1.3%)
Dec 2017
$20.78B(+6.9%)
$5.45B(+3.7%)
$20.78B(+1.0%)
Sep 2017
-
$5.25B(+2.1%)
$20.57B(+1.6%)
Jun 2017
-
$5.14B(+4.4%)
$20.24B(+1.4%)
Mar 2017
-
$4.93B(-6.0%)
$19.96B(+2.8%)
Dec 2016
$19.43B(+17.3%)
$5.24B(+6.5%)
$19.43B(+5.2%)
Sep 2016
-
$4.92B(+1.0%)
$18.47B(+4.8%)
Jun 2016
-
$4.87B(+10.9%)
$17.62B(+4.2%)
Mar 2016
-
$4.39B(+2.4%)
$16.91B(+2.1%)
Dec 2015
$16.56B(+4.3%)
$4.29B(+5.4%)
$16.56B(+0.2%)
Sep 2015
-
$4.07B(-2.3%)
$16.53B(+0.9%)
Jun 2015
-
$4.16B(+3.0%)
$16.38B(+1.7%)
Mar 2015
-
$4.04B(-5.1%)
$16.11B(+1.4%)
Dec 2014
$15.88B(-3.1%)
$4.26B(+8.6%)
$15.88B(-1.1%)
Sep 2014
-
$3.92B(+0.8%)
$16.06B(-0.9%)
Jun 2014
-
$3.89B(+2.0%)
$16.21B(-1.0%)
Mar 2014
-
$3.81B(-14.2%)
$16.36B(-0.1%)
Dec 2013
$16.39B(-7.0%)
$4.44B(+9.2%)
$16.39B(+1.5%)
Sep 2013
-
$4.07B(+0.4%)
$16.14B(+2.1%)
Jun 2013
-
$4.05B(+5.7%)
$15.81B(-2.4%)
Mar 2013
-
$3.83B(-8.6%)
$16.20B(-8.1%)
Dec 2012
$17.62B(-17.1%)
$4.19B(+12.2%)
$17.62B(-6.7%)
Sep 2012
-
$3.74B(-15.9%)
$18.88B(-7.9%)
Jun 2012
-
$4.44B(-15.4%)
$20.49B(-4.6%)
Mar 2012
-
$5.25B(-3.7%)
$21.48B(+1.1%)
Dec 2011
$21.24B(+9.0%)
$5.45B(+2.0%)
$21.24B(+1.6%)
Sep 2011
-
$5.34B(-1.6%)
$20.90B(+2.7%)
Jun 2011
-
$5.43B(+8.4%)
$20.35B(+3.4%)
Mar 2011
-
$5.01B(-2.0%)
$19.69B(+1.0%)
Dec 2010
$19.48B(+3.6%)
$5.11B(+6.5%)
$19.48B(+0.4%)
Sep 2010
-
$4.80B(+0.6%)
$19.41B(+0.1%)
Jun 2010
-
$4.77B(-0.8%)
$19.40B(+0.5%)
Mar 2010
-
$4.81B(-4.5%)
$19.29B(+2.6%)
Dec 2009
$18.81B(+6.2%)
$5.03B(+5.1%)
$18.81B(+16.5%)
Sep 2009
-
$4.79B(+2.6%)
$16.14B(-2.8%)
Jun 2009
-
$4.67B(+7.9%)
$16.61B(-3.1%)
Mar 2009
-
$4.32B(+82.6%)
$17.15B(-3.2%)
Dec 2008
$17.71B(-8.4%)
$2.37B(-54.9%)
$17.71B(-17.8%)
Sep 2008
-
$5.25B(+1.0%)
$21.56B(+3.1%)
Jun 2008
-
$5.20B(+6.4%)
$20.91B(+3.6%)
Mar 2008
-
$4.89B(-21.3%)
$20.18B(+2.9%)
Dec 2007
$19.35B(+12.1%)
$6.21B(+35.0%)
$19.60B(+15.7%)
Sep 2007
-
$4.60B(+2.9%)
$16.94B(+2.7%)
Jun 2007
-
$4.47B(+3.6%)
$16.50B(-2.4%)
Mar 2007
-
$4.32B(+21.4%)
$16.90B(-2.1%)
Dec 2006
$17.26B(-7.3%)
$3.56B(-14.4%)
$17.26B(-4.8%)
Sep 2006
-
$4.15B(-14.7%)
$18.12B(-3.3%)
Jun 2006
-
$4.87B(+4.2%)
$18.73B(-0.1%)
Mar 2006
-
$4.68B(+5.9%)
$18.75B(+0.8%)
DateAnnualQuarterlyTTM
Dec 2005
$18.61B(-4.0%)
$4.42B(-7.3%)
$18.61B(-3.8%)
Sep 2005
-
$4.77B(-2.5%)
$19.34B(-0.1%)
Jun 2005
-
$4.89B(+7.9%)
$19.36B(+0.4%)
Mar 2005
-
$4.53B(-12.1%)
$19.29B(-0.5%)
Dec 2004
$19.38B(+3.9%)
$5.16B(+7.9%)
$19.38B(+9.8%)
Sep 2004
-
$4.78B(-0.9%)
$17.65B(-3.3%)
Jun 2004
-
$4.82B(+4.2%)
$18.24B(-1.7%)
Mar 2004
-
$4.63B(+35.1%)
$18.55B(-0.5%)
Dec 2003
$18.65B(+3.0%)
$3.42B(-36.3%)
$18.65B(-6.8%)
Sep 2003
-
$5.37B(+4.7%)
$20.01B(+4.4%)
Jun 2003
-
$5.13B(+8.5%)
$19.18B(+5.5%)
Mar 2003
-
$4.73B(-1.1%)
$18.17B(+0.4%)
Dec 2002
$18.11B(+0.7%)
$4.78B(+5.4%)
$18.11B(+0.9%)
Sep 2002
-
$4.54B(+9.9%)
$17.94B(+0.2%)
Jun 2002
-
$4.13B(-11.5%)
$17.90B(-3.1%)
Mar 2002
-
$4.66B(+1.1%)
$18.48B(-0.2%)
Dec 2001
$17.99B(-1.3%)
$4.61B(+2.5%)
$18.51B(-0.9%)
Sep 2001
-
$4.50B(-4.4%)
$18.68B(-0.3%)
Jun 2001
-
$4.71B(+0.4%)
$18.75B(-2.9%)
Mar 2001
-
$4.69B(-2.0%)
$19.31B(+1.2%)
Dec 2000
$18.22B(+7.9%)
$4.78B(+4.8%)
$19.07B(+1.0%)
Sep 2000
-
$4.56B(-13.5%)
$18.88B(+2.0%)
Jun 2000
-
$5.28B(+18.5%)
$18.51B(+2.0%)
Mar 2000
-
$4.45B(-3.0%)
$18.15B(-2.2%)
Dec 1999
$16.88B(+12.1%)
$4.59B(+9.5%)
$18.55B(+18.7%)
Sep 1999
-
$4.19B(-14.8%)
$15.63B(-2.1%)
Jun 1999
-
$4.92B(+1.4%)
$15.96B(+3.2%)
Mar 1999
-
$4.85B(+192.1%)
$15.47B(+2.7%)
Dec 1998
$15.06B(-9.8%)
$1.66B(-63.3%)
$15.06B(-15.6%)
Sep 1998
-
$4.52B(+2.1%)
$17.84B(+2.1%)
Jun 1998
-
$4.43B(-0.4%)
$17.47B(+2.1%)
Mar 1998
-
$4.45B(+0.1%)
$17.10B(+2.4%)
Dec 1997
$16.70B(+10.9%)
$4.44B(+7.0%)
$16.70B(+3.0%)
Sep 1997
-
$4.15B(+2.1%)
$16.21B(+2.6%)
Jun 1997
-
$4.06B(+0.5%)
$15.81B(+2.4%)
Mar 1997
-
$4.04B(+2.3%)
$15.44B(+2.5%)
Dec 1996
$15.06B(+9.4%)
$3.96B(+5.6%)
$15.06B(+2.4%)
Sep 1996
-
$3.75B(+1.3%)
$14.72B(+2.3%)
Jun 1996
-
$3.70B(+0.7%)
$14.39B(+1.8%)
Mar 1996
-
$3.67B(+1.7%)
$14.13B(+2.7%)
Dec 1995
$13.77B(+14.9%)
$3.61B(+5.7%)
$13.77B(+2.7%)
Sep 1995
-
$3.41B(-0.9%)
$13.41B(+3.7%)
Jun 1995
-
$3.44B(+4.4%)
$12.93B(+3.8%)
Mar 1995
-
$3.30B(+1.6%)
$12.45B(+3.9%)
Dec 1994
$11.98B(+5.0%)
$3.25B(+10.8%)
$11.98B(+2.2%)
Sep 1994
-
$2.93B(-1.3%)
$11.73B(+0.6%)
Jun 1994
-
$2.97B(+4.8%)
$11.66B(+1.5%)
Mar 1994
-
$2.83B(-5.3%)
$11.49B(+0.7%)
Dec 1993
$11.41B(+2.3%)
$2.99B(+4.6%)
$11.41B(+5.6%)
Sep 1993
-
$2.86B(+2.1%)
$10.81B(-2.2%)
Jun 1993
-
$2.80B(+1.7%)
$11.05B(-0.7%)
Mar 1993
-
$2.75B(+15.3%)
$11.13B(-0.3%)
Dec 1992
$11.16B(-0.0%)
$2.39B(-23.0%)
$11.16B(-4.7%)
Sep 1992
-
$3.10B(+7.7%)
$11.70B(+3.0%)
Jun 1992
-
$2.88B(+3.5%)
$11.36B(+1.3%)
Mar 1992
-
$2.78B(-5.2%)
$11.21B(+0.4%)
Dec 1991
$11.16B(+8.3%)
$2.94B(+6.5%)
$11.16B(+1.8%)
Sep 1991
-
$2.76B(+1.0%)
$10.96B(+1.2%)
Jun 1991
-
$2.73B(-0.2%)
$10.82B(+2.3%)
Mar 1991
-
$2.73B(-0.0%)
$10.58B(+2.7%)
Dec 1990
$10.30B(+12.1%)
$2.74B(+4.3%)
$10.30B(+3.8%)
Sep 1990
-
$2.62B(+5.6%)
$9.92B(+3.1%)
Jun 1990
-
$2.48B(+1.1%)
$9.62B(+2.6%)
Mar 1990
-
$2.46B(+4.2%)
$9.38B(+2.1%)
Dec 1989
$9.19B(+7.4%)
$2.36B(+1.7%)
$9.19B(+2.4%)
Sep 1989
-
$2.32B(+3.4%)
$8.97B(+1.4%)
Jun 1989
-
$2.24B(-0.9%)
$8.85B(+1.6%)
Mar 1989
-
$2.27B(+5.6%)
$8.71B(+1.7%)
Dec 1988
$8.56B(+13.2%)
$2.14B(-2.4%)
$8.56B(+3.1%)
Sep 1988
-
$2.20B(+4.5%)
$8.30B(+3.8%)
Jun 1988
-
$2.10B(-0.8%)
$8.00B(+2.7%)
Mar 1988
-
$2.12B(+12.0%)
$7.79B(+3.0%)
Dec 1987
$7.56B
$1.89B(0.0%)
$7.56B(+33.3%)
Sep 1987
-
$1.89B(0.0%)
$5.67B(+50.0%)
Jun 1987
-
$1.89B(0.0%)
$3.78B(+100.0%)
Mar 1987
-
$1.89B
$1.89B

FAQ

  • What is Bristol-Myers Squibb annual revenue?
  • What is the all time high annual revenue for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual revenue year-on-year change?
  • What is Bristol-Myers Squibb quarterly revenue?
  • What is the all time high quarterly revenue for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly revenue year-on-year change?
  • What is Bristol-Myers Squibb TTM revenue?
  • What is the all time high TTM revenue for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM revenue year-on-year change?

What is Bristol-Myers Squibb annual revenue?

The current annual revenue of BMY is $48.30B

What is the all time high annual revenue for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual revenue is $48.30B

What is Bristol-Myers Squibb annual revenue year-on-year change?

Over the past year, BMY annual revenue has changed by +$3.29B (+7.32%)

What is Bristol-Myers Squibb quarterly revenue?

The current quarterly revenue of BMY is $12.34B

What is the all time high quarterly revenue for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly revenue is $12.34B

What is Bristol-Myers Squibb quarterly revenue year-on-year change?

Over the past year, BMY quarterly revenue has changed by +$865.00M (+7.54%)

What is Bristol-Myers Squibb TTM revenue?

The current TTM revenue of BMY is $48.30B

What is the all time high TTM revenue for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM revenue is $48.30B

What is Bristol-Myers Squibb TTM revenue year-on-year change?

Over the past year, BMY TTM revenue has changed by +$3.29B (+7.32%)
On this page